RxDoctor Payments Data

Young Kwak, MD

MOHS-Micrographic Surgery · Long Beach, CANPI 1922443464

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 97.9% of the total across 202 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 21.3% — the pattern of someone who eats at a lot of different presentations.

$4,754in general payments, 2019–2025

Across 202 payments — averaging $23.53 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Sanofi$583
  • Amgen$506
  • Regeneron Healthcare Solutions, Inc.$369
  • LEO Pharma Inc.$228
  • Lilly USA, LLC$216
  • plus $2K from 24 others

What the payments were for

  • Food & beverage$4,65598%
  • Education$992%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,754 in reported general payments places this provider in the 65th percentile of 144 mohs-micrographic surgery providers in California.

See all mohs-micrographic surgery providers in California

Medicare billing

Part B allowed, 2024
$530,395
Medicare patients
506
Services billed
2,363

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Clobetasol Propionate45$2,629
Fluocinolone Acetonide31$1,515
Ketoconazole80$1,315
Mupirocin180$1,204
Desonide22$1,120
Fluorouracil15$657
Triamcinolone Acetonide57$551
Clindamycin Phosphate16$526
ValacyclovirValacyclovir Hcl12$368
Gentamicin Sulfate12$342
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip22$314
Doxycycline Monohydrate14$314
Cephalexin49$157
Doxycycline Hyclate16$125
Hydrocortisone16$111

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Long Beach

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →